Get the Stockscreener App
11.40
1.81%
-0.21
After Hours:
11.34
-0.06
-0.53%
Delcath Systems Inc stock is traded at $11.40, with a volume of 530.16K.
It is down -1.81% in the last 24 hours and down -17.81% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$11.61
Open:
$11.6
24h Volume:
530.16K
Relative Volume:
0.83
Market Cap:
$397.02M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-4.0426
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
+0.71%
1M Performance:
-17.81%
6M Performance:
-28.75%
1Y Performance:
+28.96%
1-Day Range:
$11.23
$11.61
1-Week Range:
$10.92
$11.71
52-Week Range:
$7.1701
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
11.40 | 385.87M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
What analysts say about Delcath Systems Inc. stockAccelerated earnings growth - Autocar Professional
What drives Delcath Systems Inc. stock priceExceptional market performance - Autocar Professional
Delcath Systems Inc. Stock Analysis and ForecastFree Investment Case Studies - Autocar Professional
Delcath Systems Sets Q2 Earnings Date: Key Updates Expected on Liver Cancer Treatment Progress - Stock Titan
Is Delcath Systems Inc. a good long term investmentFastest-growing stock picks - Autocar Professional
Uveal Melanoma Treatment Market Growth Accelerated - openPR.com
Learn to Evaluate (DCTH) using the Charts - news.stocktradersdaily.com
Published on: 2025-07-20 17:02:46 - Autocar Professional
Principal Financial Group Inc. Has $1.50 Million Stock Holdings in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Is the Options Market Predicting a Spike in Delcath Systems Stock? - Nasdaq
With A 28% Price Drop For Delcath Systems, Inc. (NASDAQ:DCTH) You'll Still Get What You Pay For - 富途牛牛
How Delcath Systems Inc. stock performs during market volatilityFree Stock Selection - Newser
Why Delcath Systems Inc. stock attracts strong analyst attentionFree Join Group - Newser
What makes Delcath Systems Inc. stock price move sharplyFree Exclusive Access to Stock Gurus - Newser
Why We're Not Concerned Yet About Delcath Systems, Inc.'s (NASDAQ:DCTH) 29% Share Price Plunge - simplywall.st
Delcath Systems (DCTH) Plunges 9.64% Amid Clinical Trial Setbacks - AInvest
Institutional Investors in Delcath Systems, Inc. (NASDAQ:DCTH) Lost 9.7% Last Week but Have Reaped the Benefits of Longer-term Growth - 富途牛牛
(DCTH) Investment Report - news.stocktradersdaily.com
Head-To-Head Comparison: Paradigm Medical Industries (OTCMKTS:PDMI) and Delcath Systems (NASDAQ:DCTH) - Defense World
Delcath Systems (NASDAQ:DCTH) Cut to Hold at Wall Street Zen - Defense World
Delcath Systems, Inc.(NasdaqCM: DCTH) added to Russell 2500 Growth Index - MarketScreener
Delcath Systems’ (DCTH) “Overweight” Rating Reaffirmed at Stephens - Defense World
(DCTH) Technical Data - news.stocktradersdaily.com
Bank of America Corp DE Purchases 24,359 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Inc (DCTH) Shares Gap Down to $15.35 on Jun 12 - GuruFocus
Delcath Systems: Growing Fast, But Business Model Is Fragile (NASDAQ:DCTH) - Seeking Alpha
DCTH to Participate in Upcoming Virtual Meeting Hosted by Stephe - GuruFocus
DCTH to Participate in Upcoming Virtual Meeting Hosted by Stephens | DCTH Stock News - GuruFocus
NBC Securities Inc. Buys 9,990 Shares of Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
How to Take Advantage of moves in (DCTH) - news.stocktradersdaily.com
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.03%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):